Bain Capital Public Equity LP

Search
⚲

Bain Capital Public Equity LP ✚
CRD #	145650
SEC #	801-69070
CIK #	0001962552, 0001156175
AUM	242.2 M (2026-03-31)
Employees	26 (15% Investors, 0% Brokers)
Fees
Minimum
Phone	617-516-2318
Address	200 Clarendon Street Boston, MA 02116
Source	[IAPD] [EDGAR] [Website] [Twitter] [LinkedIn]

Total AUM ($B) Copy

Sector	Form 13F Holdings	Value ($B)
	Alcoa Inc	0.0
	Taiwan Semiconductor Manufacturing Co Ltd	0.0
	Amazon Com Inc	0.0
	Apple Inc	0.0
	Performance Food Group Co	0.0
	Hubbell Inc	0.0
	Banco Santander Sa	0.0
	Netflix Inc	0.0
	Live Nation Entertainment Inc	0.0
	Burlington Stores Inc	0.0
View All

Holdings by Sector ($B)

Type	Form D Funds	Date	Sold	AUM
HF	Bain Capital Public Equity Enduring Equity Fund LP	[2023-02-17]	455.0 M	575.0 M
	Filed 2025-11-17 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
Other	Bain Capital Public Equity Coinvest IV LP	2022-02-16		21.4 M
Other	Bain Capital Public Equity Coinvest III LP	2020-07-07		27.6 M
Other	Bain Capital Public Equity Coinvest II LP	2020-07-07		1.1 M
HF	Bain Capital Public Equity Global Long Equity Fund LP	2020-02-21		1,184.6 M
Other	Bain Capital Public Equity Coinvest Docusign LP	2018-03-30		27.6 M
HF	Bain Capital Public Equity Global Partners Fund LP	[2017-09-29]	514.7 M	155.9 M
	Filed 2025-10-15 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Bain Capital Public Equity Global Industrials Fund LP	[2017-07-12]	209.7 M	255.1 M
	Filed 2019-05-31 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
HF	Brookside Capital Partners Fund III LP	2015-02-26		134.2 M
HF	Brookside Capital Partners Fund II LP	[2012-03-30]	975.5 M	112.6 M
	Filed 2017-02-23 (D/A) · Exemption 506(b), 3(c), 3(c)(7) · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose
View All

AUM Breakdown	Accounts	AUM ($B)
By Client Type
(a) Individuals (other than high net worth individuals)	0	0.0
(b) Individuals (high net worth individuals)	0	0.0
(c) Banking or thrift institutions	0	0.0
(d) Investment companies	1	0.0
(e) Business development companies	0	0.0
(f) Pooled investment vehicles	3	0.2
(g) Pension and profit sharing plans	0	0.0
(h) Charitable organizations	0	0.0
(i) State or municipal government entities	0	0.0
(j) Other investment advisers	0	0.0
(k) Insurance companies	0	0.0
(l) Sovereign wealth funds and foreign official institutions	0	0.0
(m) Corporations or other businesses not listed above	0	0.0
(n) Other	0	0.0
Total	4	0.2
By Discretionary
Discretionary	4	0.2
Non-Discretionary	0	0.0
Total	4	0.2
By Non-United States Persons
Non-United States Persons		0.0
United States Persons		0.2
Total	4	0.2

Form D Directors	Role	# Filings	# Firms
Michael Treisman	Director, Executive Officer	57	6
Kathleen Rockey	Executive Officer	69	5
Andrew Viens	Director, Executive Officer	60	5
Sean Doherty	Executive Officer	41	5
Michael Goss	Executive Officer	26	5
Sally Dornaus	Executive Officer	69	4
Mark Moore	Executive Officer	32	4
Ranesh Ramanathan	Director, Executive Officer	33	3
Adam Koppel	Executive Officer	23	3
Colin Campbell	Executive Officer	17	3
View All

EDGAR Form	CIK	2011 - 2026
13F-HR	[0001156175]
3	[0001156175]
4	[0001156175]
5	[0001156175]
SC 13G	[0001156175]
13F-HR	[0001962552]

Form 13D/13G Filer	Form 13D/13G Subject	Filed
Bain Capital Public Equity Management LLC	Immune Design Corp	[2017-10-06]
Bain Capital Public Equity Management LLC	Mulesoft Inc	[2017-03-30]
Brookside Capital Management LLC	Concert Pharmaceuticals Inc	[2014-02-28]
Brookside Capital Management LLC	Dicerna Pharmaceuticals Inc	[2014-02-10]
Brookside Capital Management LLC	RingCentral Inc	[2014-02-07]
Brookside Capital Management LLC	RingCentral Inc	[2014-02-07]

Firm Profile (Form ADV)
Discretionary AUM	$10.5B
Serves	Institutional
Fund Types	Hedge Fund
LEI	6UYOOZUIKHTN7U75ZV92

Form 3/4/5 Subject	2011 - 2026
Brookside Capital Partners Fund LP
Mulesoft Inc
Brookside Capital Management LLC
Brookside Capital Trading Fund LP
Radius Health Inc
Brookside Capital Investors L P
Dicerna Pharmaceuticals Inc
Brookside Capital Investors II LP
Concert Pharmaceuticals Inc
Idenix Pharmaceuticals Inc
View All

Insider Transaction (Form 3/4/5)	Date	Action	Shares	Price	Value ($)
Mulesoft Inc MULE Class A Common Stock	2017-04-04	Sell	10,855	$23.85	258,892
Mulesoft Inc MULE Class A Common Stock	2017-03-17	Buy	500,000	$17.00	8,500,000
Mulesoft Inc MULE Class A Common Stock	2017-03-17	Buy	203,082	$25.06	5,089,235
Mulesoft Inc MULE Class B Common Stock · derivative	2017-03-17	Conversion	890,689
Mulesoft Inc MULE Series G Convertible Preferred Stock · derivative	2017-03-17	Conversion	890,689
Radius Health Inc NONE Common Stock	2014-06-05	Buy	500,000	$8.00	4,000,000
Radius Health Inc NONE Common Stock Warrants · derivative	2014-03-28	Buy	67,160	$6.14	412,362
Radius Health Inc NONE Series B-2 Convertible Preferred Stock · derivative	2014-03-28	Buy	26,684	$61.42	1,638,931
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-18	Sell	14,937	$38.62	576,867
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-18	Sell	250,000	$37.75	9,437,500
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-17	Sell	9,301	$36.50	339,486
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-14	Sell	50,400	$35.33	1,780,632
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-14	Sell	200,000	$35.50	7,100,000
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-12	Sell	1,500	$37.77	56,655
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-11	Sell	2,900	$38.37	111,273
Dicerna Pharmaceuticals Inc DRNA Common Stock	2014-03-11	Sell	257,100	$38.00	9,769,800
Concert Pharmaceuticals Inc CNCE SERIES B CONVERTIBLE PREFERRED STOCK · derivative	2014-02-19	Conversion	4,300,000	$0.00
Concert Pharmaceuticals Inc CNCE COMMON STOCK	2014-02-19	Buy	350,000	$14.00	4,900,000
Concert Pharmaceuticals Inc CNCE COMMON STOCK	2014-02-19	Conversion	761,062
Concert Pharmaceuticals Inc CNCE SERIES C CONVERTIBLE PREFERRED STOCK · derivative	2014-02-19	Conversion	2,000,000	$0.00
showing 20 of 27 most recent transactions

Related Firms	State	AUM
Bain Capital Private Equity LP ✚	MA	96.43 B
Bain Capital Credit LP ✚	MA	76.30 B
Bain Capital Real Estate LP ✚	MA	9,995.4 M
Bain Capital Ventures LP ✚	MA	9,837.9 M
BCSF Advisors LP ✚	MA	3,647.4 M
Bain Capital Partnership Strategies LP ✚	MA	1,652.2 M
Bain Capital Public Equity LP ✚	MA	242.2 M
Bain Capital Credit CLO Advisors LP ✚	MA

Comparable Firms	State	AUM
Metronome Capital LLP ✚		244.9 M
Kultura Capital Management LP ✚	UT	244.7 M
Bandera Partners LLC ✚	NY	244.1 M
ShoreVest Partners Ltd ✚		244.0 M
Little Harbor Advisors LLC ✚	MA	242.6 M
DFN Management LLC ✚	FL	241.4 M
Tenere Capital LLC ✚	NY	241.1 M
English Capital Management LLC ✚	MI	241.1 M
Armatus Capital Management LLC ✚		241.0 M
Clearfield Capital Management LP ✚	NY	240.2 M

Bain Capital Public Equity LP

Assets, Funds, Holdings